Literature DB >> 21993833

A dysphagia study in patients with sporadic inclusion body myositis (s-IBM).

Ken-Ya Murata1, Ken Kouda, Fumihiro Tajima, Tomoyoshi Kondo.   

Abstract

The nature of the swallowing impairment in patients with sporadic inclusion body myositis (s-IBM) has not been well characterized. In this study, we examined ten consecutive s-IBM patients using videofluoroscopy (VF) and computed pharyngoesophageal manometry (CPM). The patients were divided into two groups: patients with complaint and without complaint of dysphagia. VF results indicated pharyngeal muscle propulsion (PP) at the hypopharyngeal and upper esophagus sphincter (UES) in all s-IBM patients. Patients without complaint of dysphagia showed a mild degree of PP, whereas a severe form of PP was observed in patients with complaint of dysphagia. CPM revealed that negative pressure during UES opening was not observed in the s-IBM patients with complaint of dysphagia. Incomplete opening and PP at the UES were observed in all s-IBM patients. These results indicate that the dysphagic processes occur subclinically in s-IBM patients who may not report swallowing impairments.

Entities:  

Mesh:

Year:  2011        PMID: 21993833     DOI: 10.1007/s10072-011-0814-y

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  17 in total

1.  Inflammatory myopathy causing pharyngeal dysphagia: a new entity.

Authors:  J Shapiro; S Martin; U DeGirolami; R Goyal
Journal:  Ann Otol Rhinol Laryngol       Date:  1996-05       Impact factor: 1.547

2.  Inclusion body myositis with cricopharyngeus muscle involvement and severe dysphagia.

Authors:  A Verma; W G Bradley; A M Adesina; R Sofferman; W W Pendlebury
Journal:  Muscle Nerve       Date:  1991-05       Impact factor: 3.217

3.  A penetration-aspiration scale.

Authors:  J C Rosenbek; J A Robbins; E B Roecker; J L Coyle; J L Wood
Journal:  Dysphagia       Date:  1996       Impact factor: 3.438

4.  Inclusion body myositis associated with progressive dysphagia: treatment with cricopharyngeal myotomy.

Authors:  M J Danon; M Friedman
Journal:  Can J Neurol Sci       Date:  1989-11       Impact factor: 2.104

5.  Cineroentgenographic observations of the cricopharyngeus.

Authors:  W B Seaman
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1966-04

Review 6.  Inclusion body myositis and myopathies.

Authors:  R C Griggs; V Askanas; S DiMauro; A Engel; G Karpati; J R Mendell; L P Rowland
Journal:  Ann Neurol       Date:  1995-11       Impact factor: 10.422

7.  Cricopharyngeal muscle dysfunction in the differential diagnosis of dysphagia in polymyositis.

Authors:  F Dietz; J A Logeman; V Sahgal; F R Schmid
Journal:  Arthritis Rheum       Date:  1980-04

8.  Inclusion body myositis. Observations in 40 patients.

Authors:  B P Lotz; A G Engel; H Nishino; J C Stevens; W J Litchy
Journal:  Brain       Date:  1989-06       Impact factor: 13.501

9.  Role of pharyngeal propulsion as an indicator for upper esophageal sphincter myotomy.

Authors:  J L St Guily; A Moine; S Périé; C Bokowy; B Angelard; S Chaussade
Journal:  Laryngoscope       Date:  1995-07       Impact factor: 3.325

10.  Dysphagia in patients with inclusion body myositis.

Authors:  S M Houser; L H Calabrese; M Strome
Journal:  Laryngoscope       Date:  1998-07       Impact factor: 3.325

View more
  9 in total

1.  ANT1 is reduced in sporadic inclusion body myositis.

Authors:  E Barca; M Aguennouz; A Mazzeo; S Messina; A Toscano; G L Vita; S Portaro; D Parisi; C Rodolico
Journal:  Neurol Sci       Date:  2012-02-21       Impact factor: 3.307

Review 2.  Update on Inclusion Body Myositis.

Authors:  Duaa Jabari; V V Vedanarayanan; Richard J Barohn; Mazen M Dimachkie
Journal:  Curr Rheumatol Rep       Date:  2018-06-28       Impact factor: 4.592

3.  Botulinum toxin and rehabilitation treatment in inclusion body myositis for severe oropharyngeal dysphagia.

Authors:  Chiara Di Pede; Stefano Masiero; Valentina Bonsangue; Rosario Marchese Ragona; Alessandra Del Felice
Journal:  Neurol Sci       Date:  2016-04-20       Impact factor: 3.307

4.  Seropositivity for NT5c1A antibody in sporadic inclusion body myositis predicts more severe motor, bulbar and respiratory involvement.

Authors:  N A Goyal; T M Cash; U Alam; S Enam; P Tierney; N Araujo; F H Mozaffar; A Pestronk; T Mozaffar
Journal:  J Neurol Neurosurg Psychiatry       Date:  2015-04-09       Impact factor: 10.154

5.  Cricopharyngeal bar on videofluoroscopy: high specificity for inclusion body myositis.

Authors:  Kenichiro Taira; Toshiyuki Yamamoto; Madoka Mori-Yoshimura; Kazuaki Sajima; Hotake Takizawa; Jun Shinmi; Yasushi Oya; Ichizo Nishino; Yuji Takahashi
Journal:  J Neurol       Date:  2020-09-26       Impact factor: 4.849

6.  Intraoral pressure patterns during swallowing.

Authors:  Petra Santander; Wilfried Engelke; Arno Olthoff; Christiane Völter
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-12-13       Impact factor: 2.503

Review 7.  Immune and myodegenerative pathomechanisms in inclusion body myositis.

Authors:  Christian W Keller; Jens Schmidt; Jan D Lünemann
Journal:  Ann Clin Transl Neurol       Date:  2017-05-16       Impact factor: 4.511

8.  Misdiagnosis of inclusion body myositis: two case reports and a retrospective chart review.

Authors:  Amaiak Chilingaryan; Richard A Rison; Said R Beydoun
Journal:  J Med Case Rep       Date:  2015-08-13

9.  Anti-U3 ribonucleoprotein antibody-positive inflammatory myopathy: a case report.

Authors:  Ken-Ya Murata; Kumiko Nakatani; Mika Yananeki; Ichiro Nakanishi; Hidefumi Ito
Journal:  J Med Case Rep       Date:  2016-06-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.